ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.
ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024
What is the news?
A study was conducted by the healthcare workers (HCW) in India to understand the effectiveness of vaccines in India.
About the effectiveness of vaccines:
- The study involved 515 healthcare workers from 13 states and 22 cities, 305 male of whom were male.
- These healthcare workers have been administered either of the two vaccines, Covishield and Covaxin. Further, they are chosen with or without a past history of Covid-19 infection.
Read Also :-India approves COVID-19 vaccines Covishield
Key Findings regarding the effectiveness of vaccines:
- Higher Seropositivity: Among the 515 healthcare workers, 95% showed seropositivity (higher antibodies) after two doses of both vaccines.
- Seropositivity: It refers to the presence of specific antibodies in an individual.
- Higher Antibodies: Covishield vaccine has produced more antibodies than the Covaxin doses.
- Antibody: It is a protein produced by the body’s immune system when it detects harmful substances called antigens.
- Breakthrough infections: A total of 27 breakthrough infections (4.9%) were recorded among the respondents. However, there were relatively fewer instances of ‘breakthrough infections’ after taking Covaxin than Covishield.
- Breakthrough infection: It is a case of illness in which a vaccinated individual becomes sick from the same disease for which the vaccine was administered.
- Side Effects: There were mild to moderate adverse events associated with both the vaccines, but there were no serious side effects observed during the study.
Source: The Hindu
